Marko Mihic

457 total citations
8 papers, 346 citations indexed

About

Marko Mihic is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics. According to data from OpenAlex, Marko Mihic has authored 8 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Epidemiology and 2 papers in Genetics. Recurrent topics in Marko Mihic's work include Diabetes Management and Research (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Marko Mihic is often cited by papers focused on Diabetes Management and Research (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Marko Mihic collaborates with scholars based in Canada, United States and France. Marko Mihic's co-authors include Pankaj Modi, Andrew Lewin, Carol Palmason, Thomas M.S. Wolever, Robert G. Josse, David M. Nathan, Jean‐Louis Chiasson, Lawrence A. Leiter, Robert M. Cohen and Alicia Schiffrin and has published in prestigious journals such as Diabetes Care, Diabetes Research and Clinical Practice and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Marko Mihic

8 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marko Mihic Canada	7	245	75	71	45	43	8	346
N.K. Nayuni United Kingdom	7	92 0.4×	56 0.7×	137 1.9×	17 0.4×	11 0.3×	7	333
E. A. Ryan Canada	8	207 0.8×	132 1.8×	66 0.9×	4 0.1×	52 1.2×	13	464
John D. Bucheit United States	9	227 0.9×	110 1.5×	122 1.7×	29 0.6×	4 0.1×	17	358
Camelia Diaconu Romania	11	66 0.3×	36 0.5×	53 0.7×	11 0.2×	14 0.3×	35	307
Marisol Chang United States	6	57 0.2×	87 1.2×	129 1.8×	7 0.2×	23 0.5×	7	350
Hiroshi Ikegami Japan	7	102 0.4×	29 0.4×	30 0.4×	9 0.2×	38 0.9×	19	230
Jiadan Yang China	11	128 0.5×	70 0.9×	234 3.3×	6 0.1×	11 0.3×	27	452
Maham Kashif Italy	6	130 0.5×	49 0.7×	55 0.8×	4 0.1×	29 0.7×	7	310
Alice Halim China	6	88 0.4×	29 0.4×	104 1.5×	5 0.1×	19 0.4×	12	347
Washington Finkelstein United States	5	43 0.2×	213 2.8×	43 0.6×	8 0.2×	17 0.4×	7	342

Countries citing papers authored by Marko Mihic

Since Specialization

Citations

This map shows the geographic impact of Marko Mihic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Mihic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Mihic more than expected).

Fields of papers citing papers by Marko Mihic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Mihic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Mihic. The network helps show where Marko Mihic may publish in the future.

Co-authorship network of co-authors of Marko Mihic

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Mihic. A scholar is included among the top collaborators of Marko Mihic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Mihic. Marko Mihic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mihic, Marko & Pankaj Modi. (2008). Metabolic Syndrome - Risk Factors for Atherosclerosis and Diabetes. Current Diabetes Reviews. 4(2). 122–128. 11 indexed citations

2.

Guevara‐Aguirre, Jaime, et al.. (2004). Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes/Metabolism Research and Reviews. 20(6). 472–478. 25 indexed citations

3.

Guevara‐Aguirre, Jaime, et al.. (2004). Beneficial Effects of Addition of Oral Spray Insulin (Oralin) on Insulin Secretion and Metabolic Control in Subjects with Type 2 Diabetes Mellitus Suboptimally Controlled on Oral Hypoglycemic Agents. Diabetes Technology & Therapeutics. 6(1). 1–8. 23 indexed citations

4.

Modi, Pankaj, Marko Mihic, & Andrew Lewin. (2002). The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist? System. Diabetes/Metabolism Research and Reviews. 18(S1). S38–S42. 76 indexed citations

5.

Modi, Pankaj & Marko Mihic. (2000). A comparison of oral insulin versus S.C. injection in type-2 diabetic patients. Diabetes Research and Clinical Practice. 50. 37–38. 1 indexed citations

6.

Chiasson, Jean‐Louis, Robert G. Josse, Lawrence A. Leiter, et al.. (1996). The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance. Diabetes Care. 19(11). 1190–1193. 135 indexed citations

7.

Schiffrin, Alicia, Marko Mihic, B. S. Leibel, & A. M. Albisser. (1985). Computer-assisted Insulin Dosage Adjustment. Diabetes Care. 8(6). 545–552. 64 indexed citations

8.

Mihic, Marko, et al.. (1975). Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.. PubMed. 112(13 Spec No). 80–2. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact